title: Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study.
abstract: BACKGROUND
  There are only a few large prospective studies involving evaluation of the effect of maternal thyroid dysfunction on offspring and observations are inconsistent.
  
  
  OBJECTIVE
  The objective of the study was to investigate the effects of thyroid dysfunction or antibody positivity on perinatal outcome.
  
  
  METHODS
  The study included prospective population-based Northern Finland Birth Cohort 1986 including 9247 singleton pregnancies. First-trimester maternal serum samples were analyzed for thyroid hormones [TSH, free T(4) (fT4)] and antibodies [thyroid-peroxidase antibody (TPO-Ab) and thyroglobulin antibody (TG-Ab)]. Mothers were classified by their hormone and antibody status into percentile categories based on laboratory data and compared accordingly.
  
  
  RESULTS
  Outcomes were perinatal mortality, preterm delivery, absolute and gestational age-adjusted birth weight, and absolute and relative placental weight.
  
  
  RESULTS
  The offspring of TPO-Ab- and TG-Ab-positive mothers had higher perinatal mortality, which was not affected by thyroid hormone status. Unadjusted and adjusted (for maternal age and parity) risk for increased perinatal mortality was an odds ratio of 3.1 (95% confidence interval 1.4-7.1) and 3.2 (1.4-7.1) in TPO-Ab- and 2.6 (1.1-6.2) and 2.5 (1.1-5.9) in TG-Ab-positive mothers. TPO-Ab-positive mothers had more large-for-gestational age infants (2.4 vs. 0.8%, P = 0.017), as did mothers with low TSH and high fT4 concentrations vs. reference group (6.6 vs. 2.5%, P = 0.045). Significantly higher placental weights were observed among mothers with low TSH and high fT4 or high TSH and low fT4 levels as well as among TPO-Ab-positive mothers.
  
  
  CONCLUSIONS
  First-trimester antibody positivity is a risk factor for perinatal death but not thyroid hormone status as such. Thyroid dysfunction early in pregnancy seems to affect fetal and placental growth.
authors.affiliation: Department of Obstetrics and Gynecology, University of Oulu, 90014 Oulu, Finland.
authors.forename: Tuija
authors.initials: T
authors.lastname: Männistö
authors.forename: Marja
authors.initials: M
authors.lastname: Vääräsmäki
authors.forename: Anneli
authors.initials: A
authors.lastname: Pouta
authors.forename: Anna-Liisa
authors.initials: AL
authors.lastname: Hartikainen
authors.forename: Aimo
authors.initials: A
authors.lastname: Ruokonen
authors.forename: Heljä-Marja
authors.initials: HM
authors.lastname: Surcel
authors.forename: Aini
authors.initials: A
authors.lastname: Bloigu
authors.forename: Marjo-Riitta
authors.initials: MR
authors.lastname: Järvelin
authors.forename: Eila
authors.initials: E
authors.lastname: Suvanto-Luukkonen
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000097:blood*; D001724:Birth Weight; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007453:Iodide Peroxidase / Q000276:immunology*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology*; D011446:Prospective Studies; D013954:Thyroglobulin / Q000276:immunology*; D013959:Thyroid Diseases / Q000503:physiopathology*; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood
chemical_list: D001323:Autoantibodies; D013972:Thyrotropin; D013954:Thyroglobulin; D007453:Iodide Peroxidase; D013974:Thyroxine